Biomarkers Accurately Predict Cytokine Release Syndrome (CRS) after Chimeric Antigen Receptor (CAR) T Cell Therapy for Acute Lymphoblastic Leukemia (ALL)

Overview of attention for article published in Blood, December 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

policy: 1 policy source

patent: 10 patents

Readers on

mendeley: 25 Mendeley

So far, Altmetric has seen 10 patents that reference this research output.

Articles of manufacture and methods related to toxicity associated with cell therapy

Grant AU-2018275891-B2

Australia

27 Feb 2025

Methods associated with tumor burden for assessing response to a cell therapy

Grant US-12168027-B2

United States of America

17 Dec 2024

Determining toxicity risk in CAR T-cell therapy

Grant US-12163952-B2

United States of America

10 Dec 2024

Methods of assessing or monitoring a response to a cell therapy

Grant US-12031975-B2

United States of America

09 Jul 2024

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 6 additional patents.